Pepscan Therapeutics


Pepscan is a premium service provider for Life Sciences. As the inventor of peptide-based epitope mapping, Pepscan has more than 25 years expertise in providing custom peptide and epitope mapping services. Pepscan’s proprietary CLIPS technology allows 3D-structured mimicking of functional protein surfaces in a controlled fashion. The usage of CLIPS peptides also enables the identification of both discontinuous and conformational epitopes that cannot be mapped with linear peptides.

Another major advantage of our technology is the validated reusability of Pepscan’s peptide arrays allowing screening of future series of antibodies in a cost-efficient manner. Pepscan most recently also launched a phage display platform using the same CLIPS conformational peptide mimics to identify potent compounds targeting various epitopes. Next to these services we are also capable of synthesizing custom peptides (e.g. chelator-conjugated peptides, DTPA, DOTA, NOTA) and disulfide containing (folded) peptides both for research purposes which peptides, manufactured conform to GMP.

Pepscan’s high-care scientific team provides neoantigens for personalized cancer vaccine treatment worldwide. They also help you speed up your peptide drug development with peptides manufactured conform to GMP.

For more information please visit our website:

Or contact us via email at


Festibval of Biologics


There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.